Classification systems to improve assessment of risk of bias

Journal of Clinical Epidemiology

Volumn 65, Issue 3, 2012, Pages 236-238

  Boutron, Isabelle ^a,b,c,d   Ravaud, Philippe ^a,b,c,d  

^a French Cochrane Centre   (France)

^b INSERM   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CLINICAL DECISION MAKING; COMPARATIVE EFFECTIVENESS; HEALTH CARE PERSONNEL; HUMAN; MEDICAL RESEARCH; META ANALYSIS (TOPIC); NOTE; PRIORITY JOURNAL; RATING SCALE; RESEARCH ETHICS; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); THROMBOSIS;

EPIDEMIOLOGIC RESEARCH DESIGN; GUIDELINES AS TOPIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84856004859     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.09.006     Document Type: Note

References (20)

1. S. Goodman, and K. Dickersin Metabias: a challenge for comparative effectiveness research Ann Intern Med 155 2011 61 62
2. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed October 30, 2011.
3. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060 (Pubitemid 29436453)
4. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46 (Pubitemid 32682008)
5. K.F. Schulz, I. Chalmers, R.J. Hayes, and D.G. Altman Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 1995 408 412
6. L.L. Gluud Bias in clinical intervention research Am J Epidemiol 163 2006 493 501
7. A.W. Chan, A. Hrobjartsson, M.T. Haahr, P.C. Gotzsche, and D.G. Altman Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles JAMA 291 2004 2457 2465 (Pubitemid 38669189)
8. D. Moher, B. Pham, A. Jones, D.J. Cook, A.R. Jadad, and M. Moher Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 1998 609 613 (Pubitemid 28380142)
9. L. Wood, M. Egger, L.L. Gluud, K.F. Schulz, P. Juni, and D.G. Altman Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study BMJ 336 2008 601 605 (Pubitemid 351439518)
10. D. Moher, S. Hopewell, K.F. Schulz, V. Montori, P.C. Gotzsche, and P.J. Devereaux CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c869
11. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials PLoS Med 7 3 2010 e1000251
12. D. Moher, S. Hopewell, K.F. Schulz, V. Montori, P.C. Gotzsche, and P.J. Devereaux CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials J Clin Epidemiol 63 2010 e1 e37
13. L. Hartling, M. Ospina, Y. Liang, D.M. Dryden, N. Hooton, and J. Krebs Seida Risk of bias versus quality assessment of randomised controlled trials: cross sectional study BMJ 339 2009 b4012
14. L. Hartling, K. Bond, B. Vandermeer, J. Seida, D.M. Dryden, and B.H. Rowe Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma PLoS ONE 6 2 2011 e17242
15. J.J. Kirkham, K.M. Dwan, D.G. Altman, C. Gamble, S. Dodd, and R. Smyth The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews BMJ 340 2010 c365
16. E.A. Akl, X. Sun, J.W. Busse, B.C. Johnston, M. Briel, and S. Mulla Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid J Clin Epidemiol 65 2012 262 267 [in this issue]
17. S. Hopewell, S. Dutton, L.M. Yu, A.W. Chan, and D.G. Altman The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed BMJ 340 2010 c723
18. V. Montori, M. Bhandari, P. Devereaux, B. Manns, W. Ghali, and G. Guyatt In the dark: the reporting of blinding status in randomized controlled trials J Clin Epidemiol 55 2002 787 790
19. P.J. Devereaux, B.J. Manns, W.A. Ghali, H. Quan, C. Lacchetti, and V.M. Montori Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials JAMA 285 2001 2000 2003 (Pubitemid 32366954)
20. M.T. Haahr, and A. Hrobjartsson Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors Clin Trials 3 2006 360 365 (Pubitemid 44645826)